company background image
GSK logo

GSK LSE:GSK Stock Report

Last Price

UK£16.00

Market Cap

UK£65.2b

7D

-0.9%

1Y

17.5%

Updated

18 Jun, 2024

Data

Company Financials +

GSK Stock Overview

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance1/6
Financial Health3/6
Dividends3/6

GSK plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GSK
Historical stock prices
Current Share PriceUK£16.00
52 Week HighUK£18.24
52 Week LowUK£13.03
Beta0.27
1 Month Change-9.86%
3 Month Change-2.84%
1 Year Change17.51%
3 Year Change-8.23%
5 Year Change-20.28%
Change since IPO-31.81%

Recent News & Updates

Recent updates

GSK (LON:GSK) Will Pay A Dividend Of £0.15

May 05
GSK (LON:GSK) Will Pay A Dividend Of £0.15

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

May 02
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well

Apr 19
These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well

GSK's (LON:GSK) Solid Earnings Are Supported By Other Strong Factors

Feb 07
GSK's (LON:GSK) Solid Earnings Are Supported By Other Strong Factors

We Think GSK (LON:GSK) Can Stay On Top Of Its Debt

Jan 17
We Think GSK (LON:GSK) Can Stay On Top Of Its Debt

Insufficient Growth At GSK plc (LON:GSK) Hampers Share Price

Dec 27
Insufficient Growth At GSK plc (LON:GSK) Hampers Share Price

GSK (LON:GSK) Has Announced A Dividend Of £0.14

Nov 04
GSK (LON:GSK) Has Announced A Dividend Of £0.14

Shareholder Returns

GSKGB PharmaceuticalsGB Market
7D-0.9%-1.3%-1.2%
1Y17.5%9.5%4.5%

Return vs Industry: GSK exceeded the UK Pharmaceuticals industry which returned 9.5% over the past year.

Return vs Market: GSK exceeded the UK Market which returned 4.5% over the past year.

Price Volatility

Is GSK's price volatile compared to industry and market?
GSK volatility
GSK Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement7.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.8%

Stable Share Price: GSK has not had significant price volatility in the past 3 months.

Volatility Over Time: GSK's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
171570,212Emma Walmsleywww.gsk.com

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines.

GSK plc Fundamentals Summary

How do GSK's earnings and revenue compare to its market cap?
GSK fundamental statistics
Market capUK£65.25b
Earnings (TTM)UK£4.48b
Revenue (TTM)UK£30.74b

14.6x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GSK income statement (TTM)
RevenueUK£30.74b
Cost of RevenueUK£8.40b
Gross ProfitUK£22.34b
Other ExpensesUK£17.86b
EarningsUK£4.48b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 31, 2024

Earnings per share (EPS)1.10
Gross Margin72.67%
Net Profit Margin14.59%
Debt/Equity Ratio134.3%

How did GSK perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

53%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.